abstract |
The present invention relates to the field of metabolic disorders including type II diabetes and obesity. Specifically, the present invention relates to methods for treating and / or preventing metabolic disorders using IL-18 antagonists, particularly anti-IL-18 antigen binding proteins, particularly anti-IL-18 antibodies. [Selection figure] None |